Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
LIVN LivaNova PLC
- Stocks
- Healthcare
- NASDAQ: LIVN
Price (delayed)
$44.07
Market cap
$2.4B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$4.07
Enterprise value
$2.33B
LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through
Highlights
The gross profit has grown by 10% YoY
LivaNova's revenue has increased by 8% YoY
LivaNova's quick ratio has decreased by 50% YoY and by 46% QoQ
The equity has declined by 22% since the previous quarter and by 15% year-on-year
Key stats
What are the main financial stats of LIVN
Market
Valuations
Earnings
Shares outstanding
54.53M
Market cap
$2.4B
Enterprise value
$2.33B
Price to earnings (P/E)
N/A
Price to book (P/B)
2.32
Price to sales (P/S)
1.88
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.83
Revenue
$1.28B
Gross profit
$884.26M
Operating income
$161.42M
Net income
-$222.15M
EBIT
-$130.69M
EBITDA
-$78.01M
Free cash flow
$145.52M
Per share
Balance sheet
Liquidity
EPS
-$4.07
EPS diluted
-$4.08
Free cash flow per share
$2.67
Book value per share
$19.03
Revenue per share
$23.44
TBVPS
$28.67
Total assets
$2.56B
Total liabilities
$1.52B
Debt
$669.12M
Equity
$1.03B
Working capital
$429.58M
Debt to equity
0.65
Current ratio
1.58
Quick ratio
1.27
Net debt/EBITDA
0.89
Margins
Efficiency
Dividend
EBITDA margin
-6.1%
Gross margin
69.3%
Net margin
-17.4%
Operating margin
12.7%
Return on assets
-8.9%
Return on equity
-18.1%
Return on invested capital
-12.6%
Return on capital employed
-7.2%
Return on sales
-10.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
LIVN stock price
How has the LivaNova stock price performed over time
Intraday
1.31%
1 week
19.79%
1 month
30.19%
1 year
-29.39%
YTD
-4.84%
QTD
12.19%
Financial performance
How have LivaNova's revenue and profit performed over time
Revenue
$1.28B
Gross profit
$884.26M
Operating income
$161.42M
Net income
-$222.15M
Gross margin
69.3%
Net margin
-17.4%
The company's operating income rose by 25% QoQ
LivaNova's operating margin has increased by 23% QoQ
The gross profit has grown by 10% YoY
LivaNova's revenue has increased by 8% YoY
Price vs fundamentals
How does LIVN's price correlate with its fundamentals
Growth
What is LivaNova's growth rate over time
Valuation
What is LivaNova stock price valuation
P/E
N/A
P/B
2.32
P/S
1.88
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.83
The equity has declined by 22% since the previous quarter and by 15% year-on-year
The price to book (P/B) is 10% higher than the last 4 quarters average of 2.1 but 7% lower than the 5-year quarterly average of 2.5
The price to sales (P/S) is 35% lower than the 5-year quarterly average of 2.9 and 10% lower than the last 4 quarters average of 2.1
LivaNova's revenue has increased by 8% YoY
Efficiency
How efficient is LivaNova business performance
The ROIC has plunged by 195% from the previous quarter and by 110% YoY
LivaNova's return on sales has shrunk by 184% QoQ and by 89% YoY
Dividends
What is LIVN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for LIVN.
Financial health
How did LivaNova financials performed over time
The company's total assets is 68% higher than its total liabilities
LivaNova's quick ratio has decreased by 50% YoY and by 46% QoQ
The current ratio has dropped by 50% year-on-year and by 45% since the previous quarter
LIVN's debt is 35% smaller than its equity
LIVN's debt to equity is up by 27% since the previous quarter and by 18% year-on-year
The equity has declined by 22% since the previous quarter and by 15% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.